ArticleJournal of experimental & clinical cancer research : CR2026

Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer.

Irene Taddei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.